191 related articles for article (PubMed ID: 10679517)
1. Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice.
Járai Z; Wagner JA; Goparaju SK; Wang L; Razdan RK; Sugiura T; Zimmer AM; Bonner TI; Zimmer A; Kunos G
Hypertension; 2000 Feb; 35(2):679-84. PubMed ID: 10679517
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
[TBL] [Abstract][Full Text] [Related]
3. Mesenteric vasodilation mediated by endothelial anandamide receptors.
Wagner JA; Varga K; Járai Z; Kunos G
Hypertension; 1999 Jan; 33(1 Pt 2):429-34. PubMed ID: 9931142
[TBL] [Abstract][Full Text] [Related]
4. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
5. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension.
Varga K; Wagner JA; Bridgen DT; Kunos G
FASEB J; 1998 Aug; 12(11):1035-44. PubMed ID: 9707176
[TBL] [Abstract][Full Text] [Related]
6. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats.
del Carmen García M; Adler-Graschinsky E; Celuch SM
Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):270-6. PubMed ID: 14504685
[TBL] [Abstract][Full Text] [Related]
7. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
[TBL] [Abstract][Full Text] [Related]
8. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.
Malinowska B; Kwolek G; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):562-9. PubMed ID: 11770012
[TBL] [Abstract][Full Text] [Related]
9. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.
Fride E; Foox A; Rosenberg E; Faigenboim M; Cohen V; Barda L; Blau H; Mechoulam R
Eur J Pharmacol; 2003 Feb; 461(1):27-34. PubMed ID: 12568912
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors.
Bátkai S; Pacher P; Járai Z; Wagner JA; Kunos G
Am J Physiol Heart Circ Physiol; 2004 Aug; 287(2):H595-600. PubMed ID: 15059774
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats.
Lake KD; Martin BR; Kunos G; Varga K
Hypertension; 1997 May; 29(5):1204-10. PubMed ID: 9149688
[TBL] [Abstract][Full Text] [Related]
12. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide.
Varga K; Lake K; Martin BR; Kunos G
Eur J Pharmacol; 1995 May; 278(3):279-83. PubMed ID: 7589169
[TBL] [Abstract][Full Text] [Related]
13. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
Lake KD; Compton DR; Varga K; Martin BR; Kunos G
J Pharmacol Exp Ther; 1997 Jun; 281(3):1030-7. PubMed ID: 9190833
[TBL] [Abstract][Full Text] [Related]
15. Effects of anandamide on embryo implantation in the mouse.
Liu WM; Duan EK; Cao YJ
Life Sci; 2002 Aug; 71(14):1623-32. PubMed ID: 12137909
[TBL] [Abstract][Full Text] [Related]
16. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.
Niederhoffer N; Szabo B
Br J Pharmacol; 1999 Jan; 126(2):457-66. PubMed ID: 10077239
[TBL] [Abstract][Full Text] [Related]
17. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells.
Sugiura T; Kondo S; Kishimoto S; Miyashita T; Nakane S; Kodaka T; Suhara Y; Takayama H; Waku K
J Biol Chem; 2000 Jan; 275(1):605-12. PubMed ID: 10617657
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular pharmacology of anandamide.
Högestätt ED; Zygmunt PM
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):343-51. PubMed ID: 12052048
[TBL] [Abstract][Full Text] [Related]
19. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.
Wagner JA; Abesser M; Harvey-White J; Ertl G
J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503
[TBL] [Abstract][Full Text] [Related]
20. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors.
Paria BC; Ma W; Andrenyak DM; Schmid PC; Schmid HH; Moody DE; Deng H; Makriyannis A; Dey SK
Biol Reprod; 1998 Jun; 58(6):1490-5. PubMed ID: 9623610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
